Search Within

Jonathan Eric Rosenberg

Formats
  1. Meeting Abstract (283)
  2. Journal Article (195)
  3. Review (18)
  4. Correspondence (10)
  5. Editorial (5)
  6. Guidelines (4)
  7. Book Section (2)
  8. Research Letter (2)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (520)
  2. Genitourinary Oncology Service (520)
  3. Solid Tumor Oncology Division (520)
  4. Department of Pathology and Laboratory Medicine (149)
  5. Surgery (140)
  6. Urology (137)

More Groups

People
  1. Dean Bajorin (204)
  2. Gopakumar Iyer (175)
  3. Hikmat Al-Ahmadie (134)
  4. Bernard Bochner (124)
  5. David Solit (114)
  6. Min Yuen Teo (75)

More People

Years
  1. 2025 (23)
  2. 2024 (36)
  3. 2023 (32)
  4. 2022 (36)
  5. 2021 (48)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (204)
  2. Annals of Oncology (42)
  3. European Urology (20)
  4. Clinical Genitourinary Cancer (18)
  5. Clinical Cancer Research (16)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (210)
  2. Oxford University Press (47)
  3. Elsevier Inc. (39)
  4. Elsevier Science, Inc. (36)
  5. Nature Publishing Group (36)
  6. American Association for Cancer Research (35)

More Publishers

Results (520)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-tumor activity, safety and pharmacokinetics (PK) of ASG-22CE (ASG-22ME; enfortumab vedotin) in a phase I dose escalation trial in patients (Pts) with metastatic urothelial cancer (mUC)
    Meeting Abstract

    Rosenberg, J. E.; Heath, E. I.; Van Veldhuizen, P. J.; Merchan, J. R.; Lang, J. M.; Ruether, J. D.; Petrylak, D. P.; Sangha, R. S.; Smith, D. C.; Sridhar, S. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Patterns of chemotherapy administration in bladder preservation therapy (BPT) for muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Rose, T. L.; Ladoire, S.; Crehange, G.; Galsky, M. D.; Rosenberg, J. E.; Bellmunt, J.; Powles, T.; Wong, Y. N.; Harshman, L. C.; Chowdhury, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • PD-L1 expression, Cancer Genome Atlas (TCGA) subtype, and mutational load as independent predictors of response to atezolizumab (atezo) in metastatic urothelial carcinoma (mUC; IMvigor210)
    Meeting Abstract

    Rosenberg, J. E.; Petrylak, D. P.; Van Der Heijden, M. S.; Necchi, A.; O'Donnell, P. H.; Loriot, Y.; Retz, M.; Perez-Gracia, J. L.; Bellmunt, J.; Grivas, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Differences in somatic DNA damage repair (DDR) gene alterations between primary and secondary muscle invasive bladder cancer (MIBC)
    Meeting Abstract

    Pietzak, E. J.; Bagrodia, A.; Li, Q.; Al-Ahmadie, H.; Herr, H. W.; Funt, S.; Barron, D.; Zehir, A.; Berger, M. F.; Solit, D. B.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy of BGJ398, a fibroblast growth factor receptor (FGFR) 1-3 inhibitor, in patients (pts) with previously treated advanced/metastatic urothelial carcinoma (mUC) with FGFR3 alterations
    Meeting Abstract

    Pal, S. K.; Rosenberg, J. E.; Keam, B.; Wolf, J.; Berger, R.; Dittrich, C.; Hoffman-Censits, J. H.; Quinn, D.; van der Noll, R.; Burris, H. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The RISC nomogram (RN) to predict overall survival (OS) of patients (pts) with metastatic urothelial carcinoma (mUC) receiving first-line platinum-based combination chemotherapy (CT)
    Meeting Abstract

    Necchi, A.; Sonpavde, G.; Lo Vullo, S.; Bamias, A.; Crabb, S. J.; Harshman, L. C.; Bellmunt, J.; De Giorgi, U.; Sternberg, C. N.; Ladoire, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic evolution in muscle-invasive bladder cancer resistant to neoadjuvant chemotherapy
    Meeting Abstract

    Liu, D.; Abbosh, P.; Miao, D.; Boyd, M. E.; Hoffman-Censits, J. H.; Iyer, G.; Tolaney, S. M.; Mouw, K. W.; Carter, S. L.; Bellmunt, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation of DNA damage response (DDR) gene alterations with response to neoadjuvant (neo) dose-dense gemcitabine and cisplatin (ddGC) in urothelial carcinoma (UC)
    Meeting Abstract

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation of peripheral and intratumoral T-cell receptor (TCR) clonality with clinical outcomes in patients with metastatic urothelial cancer (mUC) treated with atezolizumab
    Meeting Abstract

    Funt, S.; Charen, A. S.; Yusko, E.; Vignali, M.; Benzeno, S.; Boyd, M. E.; Moran, M. M.; Kania, B. E.; Cipolla, C. K.; Regazzi, A. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy and safety of nivolumab plus ipilimumab in metastatic urothelial carcinoma: First results from the phase I/II CheckMate 032 study
    Meeting Abstract

    Sharma, P.; Callahan, M. K.; Calvo, E.; Kim, J. W.; de Braud, F.; Ott, P. A.; Bono, P.; Pillai, R. N.; Morse, M.; Le, D. T.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save